DG
David Gao
Chief Executive OfficerDirector

David Gao insider trades: China Biologic Products (CBPO) stock buys and sales

Chief Executive Officer, China Biologic Products Last trade Mar 1, 2017 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2008
3
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 1, 2017CBPO↓ Sell$11.7M
Nov 4, 2015CBPO↓ Sell10b5-1$11.1M
Nov 2, 2015CBPO↓ Sell10b5-1$1.4M
Oct 29, 2015CBPO↓ Sell10b5-1$7.8M
Oct 26, 2015CBPO↓ Sell10b5-1$6.3M
Oct 20, 2015CBPO↓ Sell10b5-1$48K
Sep 13, 2012CBPO↑ Buy$45K
May 14, 2012CBPO↑ Buy$26K
May 11, 2012CBPO↑ Buy$41K
Aug 13, 2009BJGP↑ Buy$39K
May 22, 2008BJGP↑ Buy$71K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David Gao's insider trades

David Gao is Chief Executive Officer at China Biologic Products (CBPO). Since May 22, 2008, David has reported 5 open-market purchases worth $221K and 6 sales worth $38.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

5 sales (69% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (10 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CBPO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.